Type : |
Journal |
|
Research teams : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Authors : |
Ensom MHH, Decarie D, Sheppard I. |
Title : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Reference : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Level of Evidence : |
|
Physical stability : |
|
Chemical stability : |
|
Other methods : |
|
Comments : |
|
List of drugs
Lansoprazole
|
![Proton pump inhibitor Proton pump inhibitor](./images/Picto.504.jpg) |
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
25°C |
![Light Light](./images/Picto.528.gif) |
91 |
![Day Day](./images/Picto.542.gif) |
|
|
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
![Light Light](./images/Picto.528.gif) |
91 |
![Day Day](./images/Picto.542.gif) |
|
|
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
4°C |
![Protect from light Protect from light](./images/Picto.526.jpg) |
91 |
![Day Day](./images/Picto.542.gif) |
|
|
![Stability in solutions Stability in solutions](./images/Picto.591.jpg) |
![Glass Glass](./images/Picto.532.jpg) |
![Kapseln Kapseln](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
![Protect from light Protect from light](./images/Picto.526.jpg) |
91 |
![Day Day](./images/Picto.542.gif) |
|
|
|
|